Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch

Transplantation. 2003 Oct 27;76(8):1220-8. doi: 10.1097/01.TP.0000083896.91215.C7.

Abstract

Background: Natural killer (NK) cells use killer immunoglobulin-like receptors (KIR) that bind to self-class I major histocompatibility complex (MHC) molecules to prevent killing of autologous cells. Mismatched allografts, which do not express recipient MHC class I molecules, can therefore be potential targets for NK-cell killing. In our living related-unrelated renal transplantation program, donor-recipient pairs vary in the amount of both HLA and KIR genes they share. This provides us with a unique opportunity to dissect the influence of KIR on NK-cell function after transplantation.

Methods: Recipient NK cells were used in a cytotoxicity assay against donor peripheral blood mononuclear cells 2 days before, on the day of, and 3 days after transplantation. Results were correlated to HLA-KIR compatibility between donor and recipient.

Results: NK killing, in a direct ex vivo setting, was demonstrated to be HLA mismatch dependent. Recipient NK antidonor cytotoxicity was unaltered despite having received 2 days' treatment with cyclosporine A before transplantation. However, cytotoxicity increased 3 days after transplantation in 71% of recipients. Recipients exhibiting increased NK cytotoxicity against their donors after transplantation were found to possess more activating KIR genes specific for donor class I MHC molecules than those in whom killing activity did not increase (P<0.04).

Conclusions: NK cells are activated after transplantation despite quadruple immunosuppression, suggesting that recipient NK-cell cytotoxicity against the donor may be a previously unrecognized area of the rejection process, especially in poorly matched donor-recipient pairs where the recipient may not express the correct repertoire of inhibitory receptors to prevent killing of donor cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Cyclosporine / therapeutic use
  • Cytotoxicity, Immunologic
  • Female
  • HLA Antigens / analysis*
  • HLA Antigens / immunology
  • Histocompatibility*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation*
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / pathology*
  • Living Donors
  • Male
  • Middle Aged
  • Postoperative Period
  • Receptors, Immunologic / immunology
  • Receptors, Immunologic / metabolism*
  • Receptors, KIR
  • Time Factors
  • Tissue Donors

Substances

  • HLA Antigens
  • Immunosuppressive Agents
  • Receptors, Immunologic
  • Receptors, KIR
  • Cyclosporine